Insider trade

Aquestive Therapeutics (AQST): Chief Operating Officer sold ~$214

Cassie Jung, Chief Operating Officer at Aquestive Therapeutics, sold ~$214 of Aquestive Therapeutics shares.

~$214
Approx. value · 44 sh @ $4.87

Traded: Nov 26, 2024
Filed: Nov 27, 2024

How to read SEC Form 4

Form 4 is the filing that officers, directors and owners of more than 10% of a US-listed company must send to the SEC within two business days after they buy, sell or otherwise change their holding of the company's stock.

Full guide: What is an SEC Form 4?

What else is on file for Aquestive Therapeutics

For Aquestive Therapeutics, OQRO holds 4 insider filings (SEC Form 4 or Form 144) and 2 fund holdings reports (13F) dated in the last 90 days.

These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its AQST page.

Other recent filings by Cassie Jung, Chief Operating Officer

SEC Form 4 at Aquestive Therapeutics (AQST)Sep 8, 2025

The full history of Cassie Jung, Chief Operating Officer is on the profile page.

How this filing works

Explore the data

Other disclosures at Aquestive Therapeutics

Everything OQRO holds on this company is on its AQST page.

This is one filing. OQRO holds the rest

Insider trades filed with the SEC, stock trades disclosed by members of Congress, fund holdings from 13F filings and federal contract awards, each one in plain words next to its official filing. On this page it opens why the trade stands out, what the company did around that time, the price since, and every field of the form.

OQRO is free for everyone. No card, no trial

OQRO describes public disclosures and context calculated from them. It does not give personalized advice and does not recommend any transaction. How OQRO treats data